Postdoctoral Fellow
Regeneron Pharmaceuticals
Summary
The postdoctoral fellow position is for early career scientist trainees who have finished graduate school and received their PhDs (or MDs, DVMs, etc.) to receive rigorous scientific postdoctoral training at Regeneron under the auspices of a scientist mentor. The program spans up to four years. We are looking for Fellows who are dedicated to seeing their research project and manuscript to completion. Fellows will be expected to conduct creative mechanistic exploratory research that results in publication. The program is academic in nature - the goal is to ask fundamental questions - not to work on Regeneron therapeutic agents.
Job description
When & where
Work Location: Tarrytown, NY. Flexibility & travel: Onsite with limited travel.
What you'll do
- Conduct forward-looking and innovative research to address a novel scientific question of your choice with the guidance of a mentor.
- Receive exposure to the biotechnology industry's most successful and innovative scientists.
- Explore opportunities to pursue groundbreaking, creative biomedical research in a prestigious, well-resourced, and dynamic industry environment.
- Publish and disseminate data via external conferences and peer-reviewed publications.
- Have the opportunity to assist with mentoring and guiding interns and other junior trainees.
- Participate in postdoctoral program activities such as weekly meetings, the annual research conference, and the Postdoc Retreat.
- Present data internally at lab meetings, trainee meetings, and company-wide seminars.
- Provide reports of research progress to supervisors and program staff.
- Travel to attend or present at conferences outside Regeneron one to two times year.
Let's find out if we're a fit
- Are pursuing a doctoral degree in a relevant subject area with an expected graduation date in 2027.
- Are a scientist looking for your first postdoctoral training (or you have less than one year of postdoctoral training).
- Have outstanding scientific skills, including critical and analytical thinking.
- Demonstrated publication success as evidenced by peer-reviewed publications.
- Have good written and oral communication skills.
- Have the ability to interact dynamically and constructively with peers and cross-functionally when applicable.
Required Documents
- A full academic CV
- At least two letters of recommendation
- Responses to two essay questions
Requirements
- Pursuing a doctoral degree in a relevant subject area with an expected graduation date in 2027
- Scientist looking for first postdoctoral training or less than one year of postdoctoral training
- Outstanding scientific skills, including critical and analytical thinking
- Demonstrated publication success as evidenced by peer-reviewed publications
- Good written and oral communication skills
- Ability to interact dynamically and constructively with peers and cross-functionally
- Full academic CV
- At least two letters of recommendation
- Responses to two essay questions
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Insurance benefits
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.